Hepatitis C: Difference between revisions
From Guide to YKHC Medical Practices
| (10 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
Anyone with untreated Hepatitis C can be given | Anyone with untreated Hepatitis C (HCV) can be given glecaprevir/pibrentasvir (Mavyret™) for 8 weeks. | ||
Please call the ANMC Hepatology team with any questions and see the Resources below for a link to the Prior Authorization Form. | |||
If a patient is to be started on glecaprevir/pibrentasvir, the [http://dhss.alaska.gov/dhcs/Documents/pharmacy/forms/AK_Hep_C_DAA_Fax_Form_20171001.pdf medication prior authorization form] needs to be filled out by BOTH patient and provider prior to the medication being dispensed. It is ideal to have this form completed during the visit and given to your clinic pharmacist when sending the prescription to the pharmacy. | |||
===Resources/References=== | ===Resources/References=== | ||
*[https://www.anthc.org/wp-content/uploads/2022/05/Treatment-Checklist-Simplified.pdf Simplified Hepatitis C Treatment Checklist - ANTHC 2022] | |||
*[https://www.anthc.org/what-we-do/clinical-and-research-services/hep/hep-c-treatment-information/ Hepatitis C Treatment Webpage - ANTHC 2022] | |||
*[http://dhss.alaska.gov/dhcs/Documents/pharmacy/forms/AK_Hep_C_DAA_Fax_Form_20171001.pdf Alaska Medicaid Prior Authorization Form Hepatitis C Direct Acting Antivirals – New Starts] | *[http://dhss.alaska.gov/dhcs/Documents/pharmacy/forms/AK_Hep_C_DAA_Fax_Form_20171001.pdf Alaska Medicaid Prior Authorization Form Hepatitis C Direct Acting Antivirals – New Starts] | ||
* [[ | * [[Media:Liver Disease Updates 10.6.17.pdf|Liver Disease Updates 2017]] (PowerPoint Presentation) | ||
* [[Media:Hep C Update 2015.pdf|Hepatitis C Update 2015]] (PowerPoint Presentation) | |||
[[Practicing Medicine in Bush Alaska—Some ABCs|Common/Unique Medical Diagnoses]] | |||
Latest revision as of 10:31, 26 January 2024
Anyone with untreated Hepatitis C (HCV) can be given glecaprevir/pibrentasvir (Mavyret™) for 8 weeks.
Please call the ANMC Hepatology team with any questions and see the Resources below for a link to the Prior Authorization Form.
If a patient is to be started on glecaprevir/pibrentasvir, the medication prior authorization form needs to be filled out by BOTH patient and provider prior to the medication being dispensed. It is ideal to have this form completed during the visit and given to your clinic pharmacist when sending the prescription to the pharmacy.
